Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
ADX-88178 is a positive allosteric modulator (PAM) of metabotropic glutamate receptor 4 (mGluR4).1 It enhances glutamate-induced intracellular calcium mobilization in HEK293 cells expressing human or rat mGluR4 (EC50s = 3.5 and 9.1 nM, respectively). ADX-88178 is selective for mGluR4 over mGluR1, mGluR2, mGluR3, mGluR5, mGluR7, and the GABAB receptor at 30 µM, mGluR6 at 10 µM, and mGluR8 (EC50 = 2.2 µM). It is also selective for mGluR4 over a panel of 71 receptors, transporters, enzymes, and ion channels at 10 µM. ADX-88178 (10 mg/kg) reverses catalepsy induced by haloperidol (Item No. 12014) in rats. It enhances L-DOPA-induced decreases in motor impairments in 6-OHDA-lesioned rats in a dose-dependent manner. However, it does not reverse L-DOPA- and benserazide-induced dyskinesia in 6-OHDA-lesioned rats.2
WARNING This product is not for human or veterinary use.
1. A potent and selective metabotropic glutamate receptor 4 positive allosteric modulator improves movement in rodent models of Parkinson’s disease. J. Pharmacol. Exp. Ther. 343(1), 167-177 (2012).
2. Metabotropic glutamate receptor 4 (mGlu4) positive allosteric modulators lack efficacy in rat and marmoset models of L-